Log in to save to my catalogue

CB(1) cannabinoid receptor antagonism promotes remodeling and cannabinoid treatment prevents endothe...

CB(1) cannabinoid receptor antagonism promotes remodeling and cannabinoid treatment prevents endothe...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_73232355

CB(1) cannabinoid receptor antagonism promotes remodeling and cannabinoid treatment prevents endothelial dysfunction and hypotension in rats with myocardial infarction

About this item

Full title

CB(1) cannabinoid receptor antagonism promotes remodeling and cannabinoid treatment prevents endothelial dysfunction and hypotension in rats with myocardial infarction

Publisher

England

Journal title

British journal of pharmacology, 2003-04, Vol.138 (7), p.1251-1258

Language

English

Formats

Publication information

Publisher

England

More information

Scope and Contents

Contents

1. To study the long-term effects of altered cannabinoid receptor activity on myocardial and vascular function, Wistar rats were treated with the selective CB(1) antagonist AM-251 (0.5 mg kg(-1) d(-1)), the potent synthetic cannabinoid HU-210 (50 micro g kg(-1) d(-1)) or vehicle for 12 weeks after coronary artery ligation or sham operation. 2. AM-2...

Alternative Titles

Full title

CB(1) cannabinoid receptor antagonism promotes remodeling and cannabinoid treatment prevents endothelial dysfunction and hypotension in rats with myocardial infarction

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_73232355

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_73232355

Other Identifiers

ISSN

0007-1188

How to access this item